Blood Research

Download original image

Therapeutic responses to eltrombopag.

a)Initial required doses to achieve target platelet count (≥50,000 cells/mL, N=13). b)Doses to maintain target platelet count (≥ 50,000 cells/mL, N=13).

Abbreviations: EOD, every other day; RFS, relapse-free survival.

Blood Res 2015;50:19~25 https://doi.org/10.5045/br.2015.50.1.19
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd